scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1022899866 |
P356 | DOI | 10.1038/NCB1469 |
P3181 | OpenCitations bibliographic resource ID | 1618106 |
P698 | PubMed publication ID | 16964248 |
P5875 | ResearchGate publication ID | 232775093 |
P50 | author | Madelon M Maurice | Q58368128 |
P2093 | author name string | Arjan B Brenkman | |
Frédéric Colland | |||
Boudewijn M T Burgering | |||
Armando van der Horst | |||
Alida M M de Vries-Smits | |||
Miranda H van Triest | |||
Niels van den Broek | |||
P2860 | cites work | Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor | Q22009126 |
Direct control of the Forkhead transcription factor AFX by protein kinase B | Q22009452 | ||
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 | Q22254000 | ||
Negative control of p53 by Sir2alpha promotes cell survival under stress | Q24291828 | ||
hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase | Q24291829 | ||
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization | Q24292930 | ||
Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity | Q24298021 | ||
Nonhydrolyzable diubiquitin analogues are inhibitors of ubiquitin conjugation and deconjugation | Q74138474 | ||
Functional proteomics mapping of a human signaling pathway | Q24298398 | ||
Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2 | Q24303581 | ||
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase | Q24310456 | ||
Growth suppression by p16ink4 requires functional retinoblastoma protein | Q24317567 | ||
FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1) | Q24338668 | ||
Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues | Q24532085 | ||
Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors | Q24537205 | ||
Regulation of the Forkhead transcription factor AFX by Ral-dependent phosphorylation of threonines 447 and 451 | Q24548249 | ||
Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation | Q24673179 | ||
Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells | Q28207530 | ||
GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7 | Q28238126 | ||
Mammalian SIRT1 represses forkhead transcription factors | Q28246430 | ||
A dynamic role of HAUSP in the p53-Mdm2 pathway | Q28253645 | ||
Mechanism and function of deubiquitinating enzymes | Q28295758 | ||
Identification of mono-ubiquitinated LDH-A in skeletal muscle cells exposed to oxidative stress | Q28571897 | ||
DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein | Q28577209 | ||
Cell cycle and death control: long live Forkheads | Q28646130 | ||
A proteomics approach to understanding protein ubiquitination | Q29547312 | ||
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction | Q29618388 | ||
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress | Q29619436 | ||
FOXO transcription factors at the interface between longevity and tumor suppression | Q29620472 | ||
Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation | Q29622825 | ||
Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation | Q33755125 | ||
JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. | Q33934548 | ||
Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family | Q34156341 | ||
JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling | Q34410199 | ||
Mechanisms controlling EGF receptor endocytosis and degradation | Q35594146 | ||
Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins | Q37535142 | ||
Ubiquitin-mediated fluorescence complementation reveals that Jun ubiquitinated by Itch/AIP4 is localized to lysosomes. | Q37570487 | ||
FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. | Q40493379 | ||
Akt activation promotes degradation of tuberin and FOXO3a via the proteasome | Q40679017 | ||
Ubiquitination and degradation of the Arg tyrosine kinase is regulated by oxidative stress | Q45286153 | ||
LET-60 RAS modulates effects of insulin/IGF-1 signaling on development and aging in Caenorhabditis elegans | Q46704659 | ||
PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2) | Q73617626 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | regulation of DNA-binding transcription factor activity | Q14820066 |
Forkhead box O4 | Q21109294 | ||
Ubiquitin specific peptidase 7 | Q21109614 | ||
P304 | page(s) | 1064-73 | |
P577 | publication date | 2006-10-01 | |
P1433 | published in | Nature Cell Biology | Q1574111 |
P1476 | title | FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP | |
P478 | volume | 8 |
Q27680523 | A Role for USP7 in DNA Replication |
Q24336529 | A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system |
Q36549512 | A gain-of-function senescence bypass screen identifies the homeobox transcription factor DLX2 as a regulator of ATM-p53 signaling |
Q37389377 | A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells |
Q39991228 | A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model |
Q38712894 | AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction. |
Q42243995 | ATM-dependent downregulation of USP7/HAUSP by PPM1G activates p53 response to DNA damage |
Q37360483 | Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin |
Q47135501 | Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+ T-regulatory cells by promoting ubiquitination of Tip60. |
Q37614692 | Adding more content to screening: reactivation of FOXO as a therapeutic strategy |
Q37888960 | Applications of post-translational modifications of FoxO family proteins in biological functions |
Q36088932 | Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins |
Q35803035 | Back to your heart: ubiquitin proteasome system-regulated signal transduction |
Q24656652 | Biosynthetic enzyme GMP synthetase cooperates with ubiquitin-specific protease 7 in transcriptional regulation of ecdysteroid target genes |
Q27331617 | C. elegans SIRT6/7 homolog SIR-2.4 promotes DAF-16 relocalization and function during stress |
Q37718344 | CDDO-Me reveals USP7 as a novel target in ovarian cancer cells |
Q36421773 | CLOCK deubiquitylation by USP8 inhibits CLK/CYC transcription in Drosophila |
Q38239700 | Cell death and deubiquitinases: perspectives in cancer |
Q80347699 | Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation |
Q49718309 | Characterization of naturally occurring pentacyclic triterpenes as novel inhibitors of deubiquitinating protease USP7 with anticancer activity in vitro |
Q92542887 | Considering the Role of Murine Double Minute 2 in the Cardiovascular System? |
Q28547943 | Crystal Structure of USP7 Ubiquitin-like Domains with an ICP0 Peptide Reveals a Novel Mechanism Used by Viral and Cellular Proteins to Target USP7 |
Q28085121 | Cullin-RING ubiquitin ligases in salicylic acid-mediated plant immune signaling |
Q90140626 | Current perspective on the regulation of FOXO4 and its role in disease progression |
Q36576047 | DNA interstrand crosslink repair and cancer |
Q35048728 | DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination |
Q38336126 | DUBs, the regulation of cell identity and disease |
Q31152155 | Data integration in physiology using Bayes' rule and minimum Bayes' factors: deubiquitylating enzymes in the renal collecting duct |
Q24322745 | Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation |
Q41923220 | Deregulation of FOXO3A during prostate cancer progression |
Q38326071 | Deubiquitinases and the new therapeutic opportunities offered to cancer |
Q35955141 | Deubiquitinases in cancer |
Q37945451 | Deubiquitinases in cancer: new functions and therapeutic options. |
Q36536984 | Deubiquitinating enzymes as novel anticancer targets |
Q36232579 | Deubiquitination of Ci/Gli by Usp7/HAUSP Regulates Hedgehog Signaling |
Q36535326 | Deubiquitination of NF-κB by Ubiquitin-Specific Protease-7 promotes transcription |
Q30415089 | Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway |
Q41838441 | Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells |
Q38125278 | Deubiquitylases from genes to organism |
Q38109871 | Deubiquitylating enzymes and DNA damage response pathways |
Q21284381 | Deubiquitylating enzymes and disease |
Q48265884 | Deubiquitylating enzymes and drug discovery: emerging opportunities. |
Q43178154 | Diabetic cardiomyopathy: catabolism driving metabolism |
Q38687425 | Diabetic cardiomyopathy: role of the E3 ubiquitin ligase |
Q48188572 | Discovery and characterization of highly potent and selective allosteric USP7 inhibitors |
Q37976004 | Dissecting cell death with proteomic scalpels |
Q45900041 | E3 ubiquitin ligase NKLAM ubiquitinates STAT1 and positively regulates STAT1-mediated transcriptional activity. |
Q21131571 | EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication |
Q64286900 | EGFR and Prion protein promote signaling via FOXO3a-KLF5 resulting in clinical resistance to platinum agents in colorectal cancer |
Q59357734 | Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases |
Q37674364 | Emerging roles of deubiquitinases in cancer-associated pathways |
Q39554519 | Enzymatic assays for assessing histone deubiquitylation activity. |
Q33373662 | Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies |
Q30609320 | Evolutionary acquisition of cysteines determines FOXO paralog-specific redox signaling |
Q36858443 | Expression of HAUSP in gliomas correlates with disease progression and survival of patients |
Q51546149 | FBXO31 protects against genomic instability by capping FOXM1 levels at the G2/M transition. |
Q26776415 | FOXO factors and breast cancer: outfoxing endocrine resistance |
Q33594004 | FOXO transcription factors: their clinical significance and regulation. |
Q90390938 | FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer |
Q59811797 | FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas |
Q34173809 | FOXO1: a potential target for human diseases |
Q37356540 | FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells |
Q54375099 | FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3. |
Q38074598 | FOXOs: signalling integrators for homeostasis maintenance |
Q41962935 | FOXP in Tetrapoda: Intrinsically Disordered Regions, Short Linear Motifs and their evolutionary significance |
Q92874259 | Forkhead Domains of FOXO Transcription Factors Differ in both Overall Conformation and Dynamics |
Q38121578 | Forkhead box class O transcription factors in liver function and disease |
Q64447846 | Forkhead box transcription factors as context-dependent regulators of lymphocyte homeostasis |
Q39000854 | Forkhead followed by disordered tail: The intrinsically disordered regions of FOXO3a. |
Q43246853 | FoxO genes are dispensable during gastrulation but required for late embryogenesis in Xenopus laevis |
Q36663162 | FoxO transcription factors in the maintenance of cellular homeostasis during aging |
Q42636934 | FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf. |
Q36334327 | FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis |
Q34362813 | FoxO, autophagy, and cardiac remodeling |
Q37129806 | Foxo in the immune system |
Q36413441 | GL-V9, a new synthetic flavonoid derivative, ameliorates DSS-induced colitis against oxidative stress by up-regulating Trx-1 expression via activation of AMPK/FOXO3a pathway |
Q34193241 | Gene expression of the tumour suppressor LKB1 is mediated by Sp1, NF-Y and FOXO transcription factors |
Q41545001 | Genome-wide association study of antibody level response to NDV and IBV in Jinghai yellow chicken based on SLAF-seq technology |
Q37387937 | HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma |
Q79168398 | HAUSP hunting the FOX(O) |
Q52947230 | HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. |
Q24297641 | HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator |
Q35913537 | HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response |
Q30395512 | Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway |
Q37311332 | Herpesvirus-associated ubiquitin-specific protease (HAUSP) modulates peroxisome proliferator-activated receptor γ (PPARγ) stability through its deubiquitinating activity. |
Q37361776 | Histone H2B ubiquitination: the cancer connection |
Q36785057 | How the ubiquitin proteasome system regulates the regulators of transcription |
Q47552231 | Human Herpesvirus 8 Interferon Regulatory Factors 1 and 3 Mediate Replication and Latency Activities via Interactions with USP7 Deubiquitinase |
Q58116151 | Identification and Characterization of USP7 Targets in Cancer Cells |
Q52655073 | Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors. |
Q36566682 | Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer |
Q36922997 | Immune regulation by Foxo transcription factors |
Q33802926 | Inactivation of HAUSP in vivo modulates p53 function |
Q33792527 | Inducible STAT3 NH2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis |
Q95648224 | Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy |
Q30427503 | Intersection of FOXO- and RUNX1-mediated gene expression programs in single breast epithelial cells during morphogenesis and tumor progression |
Q47206865 | Isolation and initial characterization of GW5, a major QTL associated with rice grain width and weight |
Q42930872 | Isolation of mammalian 26S proteasomes and p97/VCP complexes using the ubiquitin-like domain from HHR23B reveals novel proteasome-associated proteins |
Q41466923 | Isopeptidases in anticancer therapy: looking for inhibitors. |
Q24338903 | JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress |
Q37149786 | JWA regulates XRCC1 and functions as a novel base excision repair protein in oxidative-stress-induced DNA single-strand breaks |
Q42044297 | Lysosomal localization of ubiquitinated Jun requires multiple determinants in a lysine-27-linked polyubiquitin conjugate |
Q35882313 | M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability |
Q28250621 | MBD4 interacts with and recruits USP7 to heterochromatic foci |
Q39868313 | MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. |
Q21092186 | Mdm2 induces mono-ubiquitination of FOXO4 |
Q40133177 | Mechanistic studies of MDM2-mediated ubiquitination in p53 regulation |
Q35879654 | Membrane type 1 matrix metalloproteinase (MT1-MMP) ubiquitination at Lys581 increases cellular invasion through type I collagen |
Q36209138 | Methylation by Set9 modulates FoxO3 stability and transcriptional activity. |
Q33612153 | Modelling the response of FOXO transcription factors to multiple post-translational modifications made by ageing-related signalling pathways |
Q38644746 | Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity. |
Q28075457 | Modulation of the p53/MDM2 interplay by HAUSP inhibitors |
Q34248458 | Monoubiquitination of nuclear RelA negatively regulates NF-κB activity independent of proteasomal degradation |
Q40037116 | Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells |
Q24295012 | Monoubiquitylation promotes mitochondrial p53 translocation |
Q38066579 | Moving to the core: spatiotemporal analysis of Forkhead box O (FOXO) and nuclear factor-κB (NF-κB) nuclear translocation |
Q34071699 | NFX1-LIKE2 (NFXL2) suppresses abscisic acid accumulation and stomatal closure in Arabidopsis thaliana |
Q37739372 | New insights for FOXO and cell-fate decision in HIV infection and HIV associated neurocognitive disorder |
Q28594861 | Novel variant of neuronal intranuclear rodlet immunoreactive for 40 kDa huntingtin associated protein and ubiquitin in the mouse brain |
Q92529034 | Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease |
Q34352254 | Nuclear expression of the deubiquitinase CYLD is associated with improved survival in human hepatocellular carcinoma |
Q28570758 | O-GlcNAcylation enhances FOXO4 transcriptional regulation in response to stress |
Q54647572 | Oxidative Stress-Dependent Regulation of Forkhead Box O4 Activity by Nemo-Like Kinase |
Q37245117 | Oxidative stress in the regulation of normal and neoplastic hematopoiesis |
Q35951377 | PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressor |
Q50058849 | Parathyroid hormone-related protein exhibits antioxidant features in osteoblastic cells through its N-terminal and osteostatin domains. |
Q33307875 | Patented small molecule inhibitors in the ubiquitin proteasome system |
Q35559055 | Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases |
Q91714281 | Pinning Down the Transcription: A Role for Peptidyl-Prolyl cis-trans Isomerase Pin1 in Gene Expression |
Q38039281 | Post-translational regulation of FOXO. |
Q57821113 | Proteasome biology and therapeutics in cardiac diseases |
Q30437232 | Proteasome regulation of dynamic transcription factor occupancy on the GnRH-stimulated luteinizing hormone beta-subunit promoter |
Q36554464 | Protein monoubiquitylation: targets and diverse functions |
Q27312567 | RNA-processing protein TDP-43 regulates FOXO-dependent protein quality control in stress response |
Q34479990 | ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3(-/-) mice. |
Q26799843 | Redox regulation of FoxO transcription factors |
Q39817849 | Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity |
Q111285544 | Regulation of Cancer Metabolism by Deubiquitinating Enzymes: The Warburg Effect |
Q50057271 | Regulation of FOXO Factors in Mammalian Cells. |
Q35032366 | Regulation of FOXO protein stability via ubiquitination and proteasome degradation |
Q37858547 | Regulation of Foxo-dependent transcription by post-translational modifications |
Q52717506 | Regulation of cellular senescence via the FOXO4-p53 axis. |
Q38855269 | Regulation of pluripotency and differentiation by deubiquitinating enzymes |
Q38120938 | Regulation of proteolysis by human deubiquitinating enzymes |
Q37638351 | Regulation of transcription factor activity by interconnected post-translational modifications |
Q38864889 | Regulation of transcriptional activators by DNA-binding domain ubiquitination. |
Q50152340 | Regulation of vascular signalling by nuclear Sprouty2 in fetal lung epithelial cells: Implications for co-ordinated airway and vascular branching in lung development |
Q37112275 | Reverse the curse--the role of deubiquitination in cell cycle control |
Q41952089 | Role of deubiquitylase HAUSP in stem cell maintenance |
Q33307879 | Role of the ubiquitin proteasome system in renal cell carcinoma |
Q35098801 | Roles of HAUSP-mediated p53 regulation in central nervous system development |
Q36544196 | STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation |
Q35232335 | Screening of DUB activity and specificity by MALDI-TOF mass spectrometry |
Q90633486 | Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism |
Q37179308 | Serine 574 phosphorylation alters transcriptional programming of FOXO3 by selectively enhancing apoptotic gene expression |
Q34049065 | Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity. |
Q28303730 | Stressing the role of FoxO proteins in lifespan and disease |
Q38847962 | Structural Characterization of Interaction between Human Ubiquitin-specific Protease 7 and Immediate-Early Protein ICP0 of Herpes Simplex Virus-1. |
Q37129790 | Structure/function relationships underlying regulation of FOXO transcription factors |
Q43148533 | Synthesis and biological evaluation of 9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile analogues as potential inhibitors of deubiquitinating enzymes |
Q36955861 | TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling. |
Q38989377 | Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges. |
Q92002855 | Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet? |
Q26866185 | Targeting the ubiquitin pathway for cancer treatment |
Q36782222 | The C. elegans Ortholog of USP7 controls DAF-16 stability in Insulin/IGF-1-like signaling |
Q36515754 | The Caenorhabditis elegans ekl (enhancer of ksr-1 lethality) genes include putative components of a germline small RNA pathway |
Q39255653 | The Cul4A-DDB1 E3 ubiquitin ligase complex represses p73 transcriptional activity. |
Q36065142 | The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin. |
Q35852560 | The Deubiquitylase MATH-33 Controls DAF-16 Stability and Function in Metabolism and Longevity. |
Q28275268 | The FoxO code |
Q34013124 | The FoxO family in cardiac function and dysfunction |
Q35986310 | The Role of Insulin and Insulin-Like Growth Factor-1/FoxO-Mediated Transcription for the Pathogenesis of Obesity-Associated Dementia |
Q24313017 | The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1 |
Q27932371 | The Ubp15 deubiquitinase promotes timely entry into S phase in Saccharomyces cerevisiae |
Q37496493 | The WD40-repeat protein-containing deubiquitinase complex: catalysis, regulation, and potential for therapeutic intervention |
Q33761920 | The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells. |
Q39948774 | The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network |
Q28253741 | The emerging roles of forkhead box (Fox) proteins in cancer |
Q34066395 | The flavones apigenin and luteolin induce FOXO1 translocation but inhibit gluconeogenic and lipogenic gene expression in human cells. |
Q33815705 | The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies |
Q35077555 | The human T-cell leukemia virus type 1 oncoprotein tax controls forkhead box O4 activity through degradation by the proteasome |
Q28591150 | The intracellular region of Notch ligands Dll1 and Dll3 regulates their trafficking and signaling activity |
Q37862125 | The multifaceted roles of USP7: new therapeutic opportunities |
Q26749343 | The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase |
Q43118033 | The p53--Mdm2--HAUSP complex is involved in p53 stabilization by HAUSP. |
Q33804604 | The protein kinase MBK-1 contributes to lifespan extension in daf-2 mutant and germline-deficient Caenorhabditis elegans |
Q26748001 | The recognition of ubiquitinated proteins by the proteasome |
Q33857612 | The regulation of TGF-β/SMAD signaling by protein deubiquitination |
Q28267230 | The role of UBL domains in ubiquitin-specific proteases |
Q37781736 | The role of deubiquitinating enzymes in apoptosis |
Q34564968 | The role of deubiquitinating enzymes in chromatin regulation. |
Q64288182 | The role of ubiquitin-specific peptidases in cancer progression |
Q38242060 | The roles of FoxOs in modulation of aging by calorie restriction |
Q37143739 | The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X |
Q45739113 | The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle |
Q44932706 | The ubiquitin-specific protease subfamily UBP3/UBP4 is essential for pollen development and transmission in Arabidopsis |
Q41056246 | Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones |
Q101564352 | Therapeutic strategies targeting FOXO transcription factors |
Q37531925 | Therapeutic strategies within the ubiquitin proteasome system. |
Q39506544 | Transcriptome-wide effects of a POLR3A gene mutation in patients with an unusual phenotype of striatal involvement |
Q51351795 | Trip12 is an E3 ubiquitin ligase for USP7/HAUSP involved in the DNA damage response. |
Q41008451 | Tumor suppressors revival in CLL |
Q99239892 | USP19 Enhances MMP2/MMP9-Mediated Tumorigenesis in Gastric Cancer |
Q36126977 | USP2a protein deubiquitinates and stabilizes the circadian protein CRY1 in response to inflammatory signals |
Q61816131 | USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia |
Q98771728 | USP7 Is a Master Regulator of Genome Stability |
Q63246433 | USP7 Regulates Cytokinesis through FBXO38 and KIF20B |
Q33701405 | USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy. |
Q38931404 | USP7 controls Chk1 protein stability by direct deubiquitination |
Q50296509 | USP7 deubiquitinates TP53,MDM2,MDM4,FOXO4, PTEN |
Q58116419 | USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia |
Q28834083 | USP7 is a SUMO deubiquitinase essential for DNA replication |
Q33707419 | USP7/HAUSP Promotes the Sequence-Specific DNA Binding Activity of p53 |
Q42714232 | USP7/HAUSP stimulates repair of oxidative DNA lesions |
Q51665623 | USP7/HAUSP: A SUMO deubiquitinase at the heart of DNA replication. |
Q64079043 | USP7: Novel Drug Target in Cancer Therapy |
Q91936479 | USP7: Structure, substrate specificity, and inhibition |
Q36799954 | Ubiquitin and proteasomes in transcription |
Q34503492 | Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets |
Q39016984 | Ubiquitin signals proteolysis-independent stripping of transcription factors |
Q36509580 | Ubiquitin-Specific Proteases as Druggable Targets |
Q38698832 | Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis |
Q50233689 | Ubiquitin-specific protease 15 promotes tumor cell invasion and proliferation in glioblastoma |
Q35902915 | Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11β-hydroxysteroid dehydrogenase 1 |
Q53225430 | Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression. |
Q36716292 | Ubiquitin-specific protease 7 expression is a prognostic factor in epithelial ovarian cancer and correlates with lymph node metastasis |
Q50745788 | Ubiquitin-specific proteases UBP12 and UBP13 act in circadian clock and photoperiodic flowering regulation in Arabidopsis. |
Q37875076 | Ubiquitin-specific proteases as cancer drug targets |
Q35126991 | Unraveling the role of FoxOs in bone--insights from mouse models |
Q28591019 | Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1 |
Q33977038 | Usp7 protects genomic stability by regulating Bub3. |
Q27009990 | Utilizing regulatory T cells against rheumatoid arthritis |
Q24304410 | XIAP monoubiquitylates Groucho/TLE to promote canonical Wnt signaling |
Q37882073 | p53 regulation by ubiquitin |
Q82452792 | p53 stabilization: the importance of nuclear import |
Search more.